In the context of diverse Mediator roles in biological processes, it could be of interest to test CKM inhibitors as potential drugs against different types of pathologies: metabolic disorders, osteoporosis [83], autoimmunity and atherosclerosis. Here, CKM is linked to atherosclerosis.